Clinical Trials Logo

Chronobiology Disorders clinical trials

View clinical trials related to Chronobiology Disorders.

Filter by:

NCT ID: NCT04154631 Recruiting - Sleep Disorder Clinical Trials

Implementing and Sustaining a Sleep Treatment to Improve Community Mental Part 1: Implementation Health Outcomes

Start date: January 8, 2020
Phase: N/A
Study type: Interventional

The sleep disturbance commonly experienced by individuals with a severe mental illness (SMI) reduces these individuals' capacity to function and contributes to key symptoms. This study will test the effects of a sleep treatment that has been adapted using theory, data and stakeholder inputs to improve the fit for SMI patients treated in community mental health centers (CMHCs), relative to the standard treatment. The investigators will also determine if the adapted and standard versions can improve sleep, improve functioning and reduce symptoms.

NCT ID: NCT04113876 Completed - Clinical trials for Chronobiology Disorders

Circadian Health and Influential Factors

CHRONOHOSPI
Start date: January 1, 2019
Phase:
Study type: Observational [Patient Registry]

This study evaluates the quality of sleep of patients admitted to medical and intensive care units. All of them will have a clock placed to measure their circadian activity. Also, data will be recorded through questionnaires about the unit, patient habits and medical problems.

NCT ID: NCT04111900 Completed - Critical Illness Clinical Trials

Effect of Sleep on the Recovery of Patients Admitted to the ICU

Start date: February 27, 2017
Phase: N/A
Study type: Interventional

The investigators plan to create several sleep/circadian rhythm friendly rooms within the medical intensive care unit to determine if decreasing sleep fragmentation effects recovery in patients hospitalized in the ICU.

NCT ID: NCT04063332 Recruiting - Sepsis Clinical Trials

Functionality of Endogenous Biological Clock in Sepsis

Start date: June 3, 2019
Phase:
Study type: Observational

The aim of the current study is to demonstrate dysregulation of immune system΄s circadian rhythms as a consequence of sepsis, as well as marked malfunction of the central circadian clock in comparison with patients without sepsis , the presence of which burdens independently the final outcome and , hence, need to be addressed.

NCT ID: NCT04021355 Recruiting - Obesity Clinical Trials

Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans

Start date: July 14, 2020
Phase: N/A
Study type: Interventional

Experimental data have shown that timing of sodium intake impacts diurnal patterns of sodium excretion. The purpose of this study is to test the hypothesis that the time of day for salt intake impacts (1) blood pressure rhythms and urinary sodium excretion and (2) circadian timing of factors responsible for blood pressure regulation and cardiometabolic health in obese individuals. These studies will address two aims. The first aim will test the hypothesis that limiting high salt intake prior to sleep increases day-night differences in blood pressure, improves timing of urinary sodium excretion, and improves metabolic risk factors. The second aim will test the hypothesis that limiting high salt intake prior to sleep preferentially improves rhythmicity in peripheral vs. central circadian clock factors linked to renal sodium handling. The proposed hypothesis-driven studies will determine how timing of sodium intake affects diurnal blood pressure and circadian timing of factors responsible for blood pressure control and metabolic health, with the ultimate goal of identifying novel strategies to treat nocturnal hypertension and metabolic disease in obesity.

NCT ID: NCT03977441 Not yet recruiting - Depression Clinical Trials

the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease

Start date: July 2019
Phase: Phase 4
Study type: Interventional

Among the patients with Parkinson's disease, about 40%~50% will suffer from depression, 40% will suffer from anxiety, and 40%~60% will suffer from sleep disorder. These non-motor symptoms of Parkinson's disease will cause great physical and psychological pain and affect the quality of life seriously. Commonly used therapeutic drugs, such as selective serotonin reuptake inhibitor (SSRI) and clonazepam, can cause a variety of side effects, including serotonin syndrome, sexual dysfunction, daytime fatigue, insomnia, residual effects and increased risk of falls. Therefore, a new and more reasonable therapeutic choice should be sought. Agomelatine is a new type of antidepressant with novel mechanism, and can improve sleep structure and circadian rhythm. The aim of this multi-center randomized controlled trial (RCT) is to clarify the role of agomelatine in improving sleep disorders and depression in patients with Parkinson's disease

NCT ID: NCT03934177 Completed - Obesity Clinical Trials

Impact of Blueberry Consumption on Gastrointestinal Health

Start date: March 26, 2019
Phase: N/A
Study type: Interventional

This study will evaluate the impact of blueberry consumption on markers of gastrointestinal health including gut microbiota, intestinal permeability, and gut-derived inflammation in those vulnerable to a unhealthy gut milieu. All participants will consume a blueberry powder and a placebo in this crossover study.

NCT ID: NCT03747367 Recruiting - Stress Clinical Trials

The Microbiome and Resilience to Sleep and Circadian Disruption

Start date: October 21, 2015
Phase: N/A
Study type: Interventional

This study is about how sleep loss and being awake at night impacts the ability to think, changes molecules in the blood, and alters the bacteria that live in the gut that typically help keep people healthy. This work will have important implications for the development of treatments and countermeasures for people who do not sleep enough and need to be active at different times of the day and night (e.g., emergency workers and military personnel).

NCT ID: NCT03684460 Completed - Clinical trials for Circadian Rhythm Disorders

Daytime Bright Light, Circadian Abnormalities, and Delirium in Medical ICU Patients

Start date: July 8, 2019
Phase: N/A
Study type: Interventional

To determine if daytime bright light will promote circadian alignment and shorten or prevent delirium.

NCT ID: NCT03682185 Completed - Alzheimer Disease Clinical Trials

The Healthy Patterns Sleep Study

Start date: May 1, 2016
Phase: Phase 3
Study type: Interventional

The Healthy Patterns Study intervention is a home-based activity intervention designed to improve symptoms of circadian rhythm disorders (CRD) and quality of life (QOL) in home-dwelling persons with dementia. We will use a randomized two-group parallel design of 200 people with dementia and their caregivers assigned to intervention or attention control groups.